Form 4: Hanover Bancorp Director Ahron H. Haspel Receives Restricted Stock Grant

Sentiment:

SEC Form 4 Filing


Director Ahron H. Haspel received a grant of 2,117 shares of restricted Hanover Bancorp stock on March 1, 2024, vesting over five years.

Summary

  • On March 1, 2024, Ahron H. Haspel, a director of Hanover Bancorp, Inc., was granted 2,117 shares of restricted common stock.
  • These shares vest over a five-year period, with 1/5 vesting annually on March 1st, starting in 2025 and ending in 2029.
  • Following the transaction, Mr. Haspel directly owns 22,623 shares of common stock.
  • He also indirectly owns 39,673 shares through a limited liability company he controls.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, indicating stability and alignment of interests. It's a neutral to slightly positive event.

Positives

  • The grant of restricted stock aligns the director's interests with the long-term performance of the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This is a routine disclosure related to executive compensation and is common in the financial services industry to align management's interests with shareholders.

Comparison to Industry Standards

  • Granting restricted stock to directors is a common practice in the banking industry to incentivize performance and retain key personnel.
  • The vesting schedule of five years is fairly standard, aligning with long-term strategic goals.
  • Comparable companies like New York Community Bancorp (NYCB) and Valley National Bancorp (VLY) also utilize stock-based compensation for their directors.

Stakeholder Impact

  • Shareholders may view the restricted stock grant positively as it aligns the director's interests with the company's long-term success.
  • The grant has no immediate impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/01/2024Date of restricted stock grant.
03/01/2025First vesting date for the restricted stock (1/5 of the grant).
03/01/2026Second vesting date for the restricted stock (1/5 of the grant).
03/01/2027Third vesting date for the restricted stock (1/5 of the grant).
03/01/2028Fourth vesting date for the restricted stock (1/5 of the grant).
03/01/2029Final vesting date for the restricted stock (1/5 of the grant).
03/05/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.